Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study
-
* Corresponding author: Alexandros A Drosos adrosos@cc.uoi.gr
Arthritis Research & Therapy 2006, 8:R82 doi:10.1186/ar1952
Accesses
- Last 30 days: 177 accesses
- Last year: 1353 accesses
- All time: 7826 accesses
Cited by
BioMed Central: 6 citations
|
Research article
Ann-Charlotte Elkan, Niclas Håkansson, Johan Frostegård, Tommy Cederholm, Ingiäld Hafström Arthritis Research & Therapy 2009, 11:R37 (10 March 2009) |
|
Research article
Tracey E Toms, Vasileios F Panoulas, Karen MJ Douglas, Helen R Griffiths, George D Kitas Arthritis Research & Therapy 2008, 10:R145 (17 December 2008) Long term exposure to glucocorticoids does not appear to be associated with a higher prevalence of the metabolic syndrome in patients with rheumatoid arthritis, finds a cross-sectional study.
|
|
Review
Bevra H Hahn, Jennifer Grossman, Benjamin J Ansell, Brian J Skaggs, Maureen McMahon Arthritis Research & Therapy 2008, 10:213 (29 August 2008) |
|
Research article
Ann-Charlotte Elkan, Beatrice Sjöberg, Björn Kolsrud, Bo Ringertz, Ingiäld Hafström, Johan Frostegård Arthritis Research & Therapy 2008, 10:R34 (18 March 2008) A gluten-free vegan diet induces potentially atheroprotective and anti-inflammatory changes in rheumatoid arthritis patients, including reduced low density lipoprotein (LDL) and oxidated LDL levels and raised natural antibodies against phosphorylcholine.
|
|
Research article
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study Antonio Naranjo, Tuulikki Sokka, Miguel A Descalzo, Jaime Calvo-Alén, Kim Hørslev-Petersen, Reijo K Luukkainen, Bernard Combe, Gerd R Burmester, Joe Devlin, Gianfranco Ferraccioli, Alessia Morelli, Monique Hoekstra, Maria Majdan, Stefan Sadkiewicz, Miguel Belmonte, Ann-Carin Holmqvist, Ernest Choy, Recep Tunc, Aleksander Dimic, Martin Bergman, Sergio Toloza, Theodore Pincus, Arthritis Research & Therapy 2008, 10:R30 (6 March 2008) Treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs, such as methotrexate, reduces the risk of heart attacks and strokes, data from a study of 4,363 patients across 15 countries shows.
|
|
Research article
Evangelia S Lourida, Athanasios N Georgiadis, Eleni C Papavasiliou, Athanasios I Papathanasiou, Alexandros A Drosos, Alexandros D Tselepis Arthritis Research & Therapy 2007, 9:R19 (27 February 2007) |